NDC 70720-125

Xermelo

Telotristat Ethyl

Xermelo is a Oral Tablet in the Human Prescription Drug category. It is labeled and distributed by Tersera Therapeutics Llc. The primary component is Telotristat Ethyl.

• Product ID: 70720-125_167b2488-387d-4dec-9597-10f55b654c18
• NDC: 70720-125
• Product Type: Human Prescription Drug
• Proprietary Name: Xermelo
• Generic Name: Telotristat Ethyl
• Dosage Form: Tablet
• Route of Administration: ORAL
• Marketing Start Date: 2020-10-05
• Marketing Category: NDA / NDA
• Application Number: NDA208794
• Labeler Name: TerSera Therapeutics LLC
• Substance Name: TELOTRISTAT ETHYL
• Active Ingredient Strength: 250 mg/1
• Pharm Classes: Tryptophan Hydroxylase Inhibitor [EPC],Tryptophan Hydroxylase Inhibitors [MoA]
• NDC Exclude Flag: N
• Listing Certified Through: 2021-12-31

Packaging

NDC 70720-125-85

4 BOX in 1 CASE (70720-125-85) > 1 BLISTER PACK in 1 BOX (70720-125-22) > 21 TABLET in 1 BLISTER PACK

• Marketing Start Date: 2021-10-01
• NDC Exclude Flag: N
• Sample Package?: N

Drug Details

NDC Crossover Matching brand name "Xermelo" or generic name "Telotristat Ethyl"

NDC	Brand Name	Generic Name
70183-125	Xermelo	telotristat ethyl
70720-125	Xermelo	telotristat ethyl